It is a drug used to treat glaucoma and acts via decreasing aqueous humor synthesis. In this domain we have positioned ourselves as a dependable firm, engaged in offering Brimonidine Tartrate. This medication is indicated for patients with open-angle glaucoma or ocular hypertension to lower intraocular pressure. The medications is for the treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years or older. Brimonidine Tartrate significantly lowers intraocular pressure with minimal effects on cardiovascular and pulmonary parameters. It lowers intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow.